Inhibikase Therapeutics Inc (NASDAQ:IKT) traded at $3.57 at close of the session on Monday, December 16 and made an upward move of 3.78% on its previous day’s price. Looking at the stock we see that its previous close was $3.44 and the beta (5Y monthly)
Inhibikase Therapeutics Inc (NASDAQ:IKT) concluded the trading at $2.73 on Wednesday, November 27, with a rise of 15.68% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.36 and 5Y monthly beta
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
